Serva Health Insights
Welcome to the Serva Health Blog—your destination for insights on patient engagement, clinical trial support, and biopharma commercial services. Our insights are designed to provide valuable information and expert perspectives on how to enhance patient care, streamline clinical trial processes, and navigate the complexities of healthcare. Here, you’ll find articles that explore the latest trends in patient support strategies, innovative healthcare technologies, and best practices for optimizing patient outcomes. Stay informed with Serva Health as we continue to shape the future of healthcare services.
Biomedical research is about pushing the boundaries of human knowledge, today those breakthroughs rely as much on digital infrastructure as they do laboratory innovation. Data sets that once lived in secured file rooms now exist in interconnected platforms, shared across collaborators, cloud environments, and connected devices. While this has accelerated
Recruiting for a rare disease study is like searching for a needle in a haystack, blindfolded. Eligible patients are few, scattered, and often heavily reliant on their trusted healthcare providers. That’s why increasing HCP referrals in rare disease clinical trials isn’t just helpful. It’s essential. Let’s explore some smarter, more
Patient expectations have changed. From ordering groceries to managing appointments, digital convenience is now the norm. That shift doesn’t stop at healthcare, especially when it comes to how patients interact with the support programs designed to help them manage complex therapies. For biopharma companies, this means evolving patient support strategies
Patient recruitment is never simple, especially when eligibility criteria are strict and timelines are tight. The right participants can be hard to find; even harder is ensuring they’re truly qualified before they get passed to a site. That’s where the secondary screening process proves its value. It’s not always the
The pharmaceutical industry is in the midst of a profound transformation, shifting its focus from solely developing and selling drugs to providing comprehensive patient-centric care. This paradigm shift is largely fueled by rapid advancements in information technology, which are reshaping everything from drug development to patient engagement and long-term health
Clinical trials often struggle to enroll enough participants and keep them involved through study completion. In fact, an estimated 85% of trials fail to meet their patient recruitment targets, and around 80% experience delays due to enrollment shortfalls or participant dropouts. One pharmaceutical analysis found that 86% of international trials